Sunao Tokumaru, Hitoshi Ishikawa, Toshinori Soejima, Takuya Kimoto, Yosuke Takakusagi, Hiroyasu Tamamura, Hitoshi Wada, Hiroshi Taguchi, Yusuke Uchinami, Yuichi Hiroshima, Hidehiro Hojo, Takashi Kamei, Manabu Muto, Masataka Igeta.

Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.

J Radiat Res . 2023 Jun 16;64(Supplement_1):i16-i24.

Tomohiro Kondo, Masashi Kanai, Junichi Matsubara, Daisuke Yamaguchi, Takashi Ura, Tadayuki Kou, Toshinao Itani, Motoo Nomura, Taro Funakoshi, Akira Yokoyama, Keitaro Doi, Masashi Tamaoki, Michio Yoshimura, Norimitsu Uza, Takahiro Yamada, Toshihiko Masui, Sachiko Minamiguchi, Shigemi Matsumoto, Hideki Ishikawa, Manabu Muto.

Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.

Med Oncol. 2023 Apr 11;40(5):144.

Satoru Matsuda, Yuko Kitagawa, Hirofumi Kawakubo, Jun Okui, Akihiko Okamura, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki.

A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.

Esophagus. 2023 Apr;20(2):205-214.

Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako E Nakajima, Manabu Muto, Yoko Hamazaki.

Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination.

Nat Aging. 2023 Jan;3(1):82-92.

Tianxia Li, Osamu Kikuchi, Jin Zhou, Yichen Wang, Babita Pokharel, Klavdija Bastl, Prafulla Gokhale, Aine Knott, Yanxi Zhang, John G Doench, Zandra V Ho, Daniel Vt Catenacci, Adam J Bass.

Developing SHP2-based combination therapy for KRAS-amplified cancer.

JCI Insight. 2023 Feb 8;8(3):e152714.

Keiji Nihei, Keiko Minashi, Tomonori Yano, Tadakazu Shimoda, Haruhiko Fukuda, Manabu Muto, JCOG-GIESG Investigators; Junki Mizuaswa, Kohei Takizawa, Ikuo Aoyama, Akiyoshi Ishiyama, Noboru Kawata, Daisuke Kikuchi, Noboru Hanaoka, Ichiro Oda, Yoshinori Morita , Masahiro Tajika, Junko Fujiwara, Yoshinobu Yamamoto, Chikatoshi Katada, Shinichiro Hori , Hisashi Doyama, Tsuneo Oyama, Hiroko Nebiki, Kenji Amagai, Yutaro Kubota, Yasuhiro Inokuchi, Nozomu Kobayashi, Takuto Suzuki, Kingo Hirasawa, Toshihisa Takeuchi, Tomohiro Kadota.

Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508

Gastroenterology. 2023 Feb;164(2):296-299.e2.

Tatsuya Ioka,Masashi Kanai,Shogo Kobayashi,Daisuke Sakai,Hidetoshi Eguchi,Hideo Baba,Satoru Seo,Akinobu Taketomi,Tadatoshi Takayama,Hiroki Yamaue,Masahiro Takahashi,Masayuki Sho,Keiko Kamei,Jiro Fujimoto,Masanori Toyoda,Junzo Shimizu,Takuma Goto,Yoshitaro Shindo,Kenichi Yoshimura,Etsuro Hatano,Hiroaki Nagano ,Kansai Hepatobiliary Oncology Group (KHBO)

Randomized phase III study of Gemcitabine, Cisplatin plus S-1 (GCS) versus Gemcitabine, Cisplatin (GC) for Advanced Biliary Tract Cancer (KHBO1401-MITSUBA).

J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110.

Yu Uneno ,Yasuhiro Kotera , Daisuke Fujisawa, Yuki Kataoka, Kazuhiro Kosugi, Nanami Murata, Takaomi Kessoku, Akihiko Ozaki, Hirotomo Miyatake, Manabu Muto.

Development of a novel COMPAssion focused online psyChoTherapy for bereaved informal caregivers: the COMPACT feasibility trial protocol.

BMJ Open.2022 Dec 22;12(12):e067187.

Masashi Kanai.

Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.

Curr Oncol. 2022 Sep 30;29(10):7272-7284.

Takashi Murakami, Rihito Aizawa, Yukinori Matsuo, Hideki Hanazawa, Kojiro Taura, Akihisa Fukuda, Norimitsu Uza, Masahiro Shiokawa, Masashi Kanai, Etsuro Hatano, Hiroshi Seno, Manabu Muto, Takashi Mizowaki.

Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma.

Cancer Diagn Progn. 2022 Nov 3;2(6):634-640.